I.D. Rusen, M.D., is Senior Vice President, Research and Development at Vital Strategies where he leads a global team working to evaluate and publish research on the potential for improving diagnosis and treatment of tuberculosis, including clinical trials related to shorter, more tolerable treatment regimens for multidrug-resistant tuberculosis (MDR-TB).
Rusen is a notable expert in public health, with over 25 years of experience as a qualified doctor, epidemiologist and global health and development professional. His achievements include 17 years of experience as a technical advisor to both donor agencies and non-governmental organizations with respect to tuberculosis and related health problems in low-income countries, including his tenure as Coordinator of the FIDELIS Initiative. He brings this expertise to his leadership of the TREAT TB Initiative (Technology, Research, Education and Technical Assistance for Tuberculosis), a multi-year project which is spearheading the coordination and sponsorship of the STREAM randomized clinical trial, a landmark trial for shortened MDR-TB treatment currently underway in four countries.
Before joining Vital Strategies, Rusen worked for Health Canada, and served as a consultant for the Canadian International Development Agency and the World Health Organization. He has written and co-authored numerous papers and reports, including first-authored publications in IJTLD, American Journal of Public Health and the Pediatric Infectious Disease Journal. Rusen earned his medical degree from the University of Manitoba and completed a Community Medicine (Preventive Medicine) Residency and a Master of Epidemiology at the University of Toronto.